DnaJ heat shock protein family (Hsp40) member B5 pseudogene 1Genealiases: []
Q-omics provides the consensus-scored DNAJB5P1 profile across patient tissues and cancer cell-line models. DNAJB5P1 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, DNAJB5P1 is differentially expressed in 1, with the highest sampling consensus in PRAD. Additionally, DNAJB5P1 RNA expression shows 6,527 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KIRC, PRAD, and STAD as cancer lineages where DNAJB5P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for DNAJB5P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes DNAJB5P1 survival associations across molecular data types. DNAJB5P1 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible DNAJB5P1 RNA expression–survival associations across cancer types. High DNAJB5P1 expression shows unfavorable associations in KIRC, KICH, LUSC, ACC, UCS and LUAD. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for DNAJB5P1 RNA expression.
This table summarizes DNAJB5P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in PRAD for RNA.
This table ranks reproducible tumor–normal expression differences for DNAJB5P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. DNAJB5P1 shows higher tumor expression in PRAD. The PRAD box plot shows higher DNAJB5P1 RNA expression in tumor versus normal tissue (log2 FC = +0.089, t-test p = .015).
This table shows molecular features associated with DNAJB5P1 in patient tissues and cancer cell lines. In patient samples, DNAJB5P1 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set. In cancer cell lines, DNAJB5P1 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in NCI60_ALL.
